LONGER LIFE DRIVES GROWTH IN PHARMACEUTICAL PACKAGING
From Iggesund Paperboard AB
Prescription and non-prescription medications represent
a growing market for innovative packaging materials, and can offer pharmaceutical
companies the opportunity to distinguish their products for increasingly
savvy consumers.
You’ve heard about global warming—but what about
global graying? As healthcare improves around the world, people are living
longer. The increasing average life span is resulting in an older population
that suffers from more and more treatable illnesses. That is the main
reason why sales of medicines are increasing faster than average sales
growth. In 2003 global drug sales are estimated to reach the amazing sum
of 435 billion dollars, and annual growth is predicted at 9 percent in
the years immediately ahead.
“In terms of value, paper and paperboard make
up just over 35 percent of the packaging materials used for pharmaceutical
products, so this is an incredibly important market for us. If we only
retain our market share, that gives us growth, and if we can show customers
that we’re better than our competitors, the return will be even
greater,” said Guy Mallinson, business director-packaging at Iggesund
Paperboard, headquartered in Iggesund, Sweden. Iggesund Paperboard is
a business unit of the Holmen Group, one of Europe’s major forestry and
forestry products organizations, whose other interests include pulp, newsprint
and timber.
Consumer’s choice
In recent years, the value of packaging material used in Europe
is predicted to have exceeded five billion dollars, and growth over the
next decade is estimated at 60 percent. Deliveries of packaging materials
to the pharmaceutical sector are already growing twice as fast as deliveries
to other industries.
“One important reason is that people are medicating
themselves more today—a trend which is partly the forced result
of galloping health-care costs,” Mallinson explained. “An
increasing proportion of sales are over-the-counter (OTC) medicines—that
is, non-prescription drugs—where the consumer makes the final purchasing
decision at the point of sale. The selling points of the packaging become
increasingly important.”
There are two clear trends in the market. For OTC medication,
it is important to catch the consumer’s eye, so design features
are often very important to the consumer’s choice. Yet when it comes
to prescription medicines, particularly generic brands, little emphasis
is put on the design aspects of the packaging.
“Pharmaceutical packaging is characterized by
a high degree of conservatism,” Mallinson said. “To some extent
this is regulated, but I think that a more advanced packaging design could
be a good way for large pharmaceutical companies to distinguish their
innovative products from the generics. If the packaging has functions
which make daily life easier for the patient, or if it makes it harder
to take an incorrect dosage, or gives better information, then those are
added values which should definitely be able to influence sales.”
Fast, clean—and affordable
Iggesund Paperboard supplies paperboard from both its product families,
Invercote and Incada, to the pharmaceutical industry. The company’s
broad product portfolio enables customers to find the particular properties
they require for their own special paperboard packaging.
“Requirements for printability and surface properties
have increased in recent years, but the most important competitive means
are runnability and hygiene,” Mallinson commented. “Our runnability
is based to a great extent on our product uniformity together with technical
documentation and a service organization that make sure customers get
the most out of their equipment and our materials.”
Despite the expected sales increases, there is great
pressure on materials suppliers to cut costs. In order to be competitive,
suppliers must be able to offer an attractive combination of technical
performance, price, logistical service and, not least, product development.
“Our development has been that we regularly bring
to the market new grades which reduce the consumption of material, while
the protective properties remain unchanged,” concluded Mallinson.
This insulin pack from Novo Nordisk is an
example of innovative package design. The converter A. C. Schmidt produced
a pack holding 10 individually packed syringes that is compact and easy
to handle. “A more advanced packaging design could be a good way
for the large pharmaceutical companies to distinguish their innovative
products from the generics,” said Guy Mallinson, business director-packaging,
Iggesund Paperboard.
|